Cite
Guidance on the need for contraception related to use of pharmaceuticals: the Japan Agency for Medical Research and Development Study Group for providing information on the proper use of pharmaceuticals in patients with reproductive potential.
MLA
Suzuki, Nao, et al. “Guidance on the Need for Contraception Related to Use of Pharmaceuticals: The Japan Agency for Medical Research and Development Study Group for Providing Information on the Proper Use of Pharmaceuticals in Patients with Reproductive Potential.” International Journal of Clinical Oncology, vol. 27, no. 5, May 2022, pp. 829–39. EBSCOhost, https://doi.org/10.1007/s10147-022-02149-1.
APA
Suzuki, N., Takai, Y., Yonemura, M., Negoro, H., Motonaga, S., Fujishiro, N., Nakamura, E., Takae, S., Yoshida, S., Uesugi, K., Ohira, T., Katsura, A., Fujiwara, M., Horiguchi, I., Kosaki, K., Onodera, H., & Nishiyama, H. (2022). Guidance on the need for contraception related to use of pharmaceuticals: the Japan Agency for Medical Research and Development Study Group for providing information on the proper use of pharmaceuticals in patients with reproductive potential. International Journal of Clinical Oncology, 27(5), 829–839. https://doi.org/10.1007/s10147-022-02149-1
Chicago
Suzuki, Nao, Yasushi Takai, Masahito Yonemura, Hiromitsu Negoro, Shinya Motonaga, Noriko Fujishiro, Eishin Nakamura, et al. 2022. “Guidance on the Need for Contraception Related to Use of Pharmaceuticals: The Japan Agency for Medical Research and Development Study Group for Providing Information on the Proper Use of Pharmaceuticals in Patients with Reproductive Potential.” International Journal of Clinical Oncology 27 (5): 829–39. doi:10.1007/s10147-022-02149-1.